Qunying Mao

机构：China Banking Regulatory Commission, National Institutes for Food and Drug Control

发表论文 34 篇 · 总被引 1071 次 · h-index 12

代表论文

• Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates (2022 · Signal Transduction and Targeted Therapy · 被引 30)
• Research progress on vaccine efficacy against SARS-CoV-2 variants of concern (2022 · Human Vaccines & Immunotherapeutics · 被引 29)
• The next major emergent infectious disease: reflections on vaccine emergency development strategies (2022 · Expert Review of Vaccines · 被引 27)
• Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines (2022 · Frontiers in Immunology · 被引 15)
• Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV (2022 · Emerging Microbes & Infections · 被引 15)
• Development of an ELISA Assay for the Determination of SARS-CoV-2 Protein Subunit Vaccine Antigen Content (2022 · Viruses · 被引 10)